# A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease

> **NCT02562768** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 80 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** LY3154207
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02562768
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-30
- **Primary completion:** 2017-03-03
- **Final completion:** 2017-03-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562768, "A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02562768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*